RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Enterovirus Infections
Accession: DOID:9006549
browse the term
Definition: Diseases caused by ENTEROVIRUS.
Synonyms: exact_synonym: Enterovirus Infection; Enterovirus infectious disease
primary_id: MESH:D004769
xref: EFO:0007255
G
Btk
Bruton tyrosine kinase
treatment
ISO
Associated with X-linked agammaglobulinemia
RGD
PMID:10508272
RGD:124715472
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
G
Cog1
component of oligomeric golgi complex 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28446605
NCBI chr10:98,695,481...98,708,495
Ensembl chr10:98,695,423...98,709,292
G
Cog5
component of oligomeric golgi complex 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28446605
NCBI chr 6:48,242,470...48,545,185
Ensembl chr 6:48,242,482...48,529,009
G
Il10
interleukin 10
severity
ISO
DNA:SNP:promoter:-592A>C (rs1800872) (human)
RGD
PMID:28843383
RGD:14975146
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Mgat5
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28446605
NCBI chr13:38,675,776...38,959,697
Ensembl chr13:38,676,119...38,959,513
G
Mir146a
microRNA 146a
ameliorates
ISO
miRNA:increased expression:blood serum, exosome (human)
RGD
PMID:28910400 PMID:24561744
RGD:126925164 , RGD:126925173
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mx1
MX dynamin like GTPase 1
susceptibility
ISO
DNA:SNPs:promoter:g.-123C>A, g.-88G>T (rs17000900, rs2071430) (human)
RGD
PMID:24085612
RGD:126777678
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Slc22a4
solute carrier family 22 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21641380
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28446605
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St3gal4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28446605
NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:33,415,671...33,524,389
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
Rhinovirus Infections
RGD
PMID:19864593
RGD:5131210
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Cast
calpastatin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34365571
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cd1d1
CD1d1 molecule
ISO
protein:increased expression:spleen, mononuclear cell (mouse)
RGD
PMID:16817758
RGD:127345109
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
G
Cd274
CD274 molecule
treatment
ISO
RGD
PMID:30904424
RGD:40818421
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Dnm1l
dynamin 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34365571
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25396421
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Pdcd1lg2
programmed cell death 1 ligand 2
treatment
ISO
RGD
PMID:30904424
RGD:40818421
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
G
Siva1
SIVA1, apoptosis-inducing factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16683188
NCBI chr 6:131,705,323...131,709,697
Ensembl chr 6:131,705,323...131,709,690
G
Slc22a3
solute carrier family 22 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21641380
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc22a4
solute carrier family 22 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21641380
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc22a5
solute carrier family 22 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21641380
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25396421
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf8
TNF superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11745696
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Tnfsf9
TNF superfamily member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11745696
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Actb
actin, beta
ISO
protein:increased expression:serum
RGD
PMID:30817906
RGD:36947391
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Ren
renin
treatment
ISO
RGD
PMID:31638922
RGD:127285374
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Ace
angiotensin I converting enzyme
ISO
DNA:insertion/deletion:intron 16:
RGD
PMID:12458570
RGD:39939119
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
disease_progression
ISO
RGD
PMID:26347518
RGD:40818419
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Pdcd1
programmed cell death 1
disease_progression
ISO
RGD
PMID:26347518
RGD:40818419
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:serum (human)
RGD
PMID:9047083
RGD:14995307
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:missense mutation:cds:p.R194W (rs1799782) (human) DNA:SNP:intron: (rs1001581) (human)
RGD
PMID:22135187 PMID:29558945
RGD:15014793 , RGD:15036793
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
mRNA,protein:increased expression:blood cells, serum:
RGD
PMID:26893848
RGD:124713562
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
ISO
mRNA,protein:increased expression:blood cells, serum:
RGD
PMID:26893848
RGD:124713562
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Gpx1
glutathione peroxidase 1
ISO
DNA:polymorphism: :p.P198L (human)
RGD
PMID:21055077
RGD:11352821
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Pvr
PVR cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3020560 PMID:28446605
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Crp
C-reactive protein
disease_progression
ISO
RGD
PMID:14636287
RGD:9491594
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all